about
Targeting dendritic cell function during systemic autoimmunity to restore toleranceMesenchymal Stem Cell-Based Therapy for Kidney Disease: A Review of Clinical EvidenceIL-17 and IL-23 in lupus nephritis - association to histopathology and response to treatment.Systemic lupus erythematosus: from genes to organ damage.Temporal Trends in Characteristics of Newly Diagnosed Nontraumatic Osteonecrosis of the Femoral Head From 1997 to 2011: A Hospital-Based Sentinel Monitoring System in Japan.Double allogenic mesenchymal stem cells transplantations could not enhance therapeutic effect compared with single transplantation in systemic lupus erythematosus.Reno-protective effect and mechanism study of Huang Lian Jie Du Decoction on lupus nephritis MRL/lpr miceLeukocyte mitochondrial DNA alteration in systemic lupus erythematosus and its relevance to the susceptibility to lupus nephritisLeiomyosarcoma of the breast in a patient with a 10-year-history of cyclophosphamide exposure: a case report.Rituximab in severe lupus nephritis: early B-cell depletion affects long-term renal outcome.Sterile empyematous pleural effusion in a patient with systemic lupus erythematosus: a diagnostic challenge.The role of IL-23/IL-17 axis in lupus nephritis.The outcome of patients with lupus nephritis and the impact of cardiovascular risk factors.Inosine triphosphate pyrophosphatase 94C>A polymorphism: clinical implications for patients with systemic lupus erythematosus treated with azathioprine.Alternative therapies: what role do they have in the management of lupus?Chromatin as a target antigen in human and murine lupus nephritisDiagnosis and treatment of lupus nephritis flares--an update.Pediatric lupus nephritis: more options, more chances?Lupus nephritis: review of the literature.Long-term mortality and renal outcome in a cohort of 100 patients with lupus nephritis.Clinical Trials With Mesenchymal Stem Cells: An Update.Carbon monoxide inhibits T cell activation in target organs during systemic lupus erythematosus.Efficacy and safety of ocrelizumab in active proliferative lupus nephritis: results from a randomized, double-blind, phase III study.Systemic lupus erythematosus in Saudi children: long-term outcomes.Long-term follow-up in lupus nephritis patients treated with rituximab--clinical and histopathological response.Carbon monoxide exposure improves immune function in lupus-prone mice.Effect of artemisinin combined with glucocorticoid on the expressions of glucocorticoid receptor α mRNA, glucocorticoid receptor β mRNA and P300/CBP protein in lupus nephritis mice.Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.Long-term outcome in Japanese patients with lupus nephritis.
P2860
Q27687098-610220A4-9E51-46D7-958A-BD295B4E0A79Q28079089-FCD0C290-E0D0-4C2B-AACC-16361C7F8849Q35078183-471437A1-5B81-416C-A7A8-FAEF31D40EDBQ35156161-1C8A9341-415E-46DE-860F-0AE886688CD4Q35649269-99439EA6-E35D-4701-B164-9737BA9BC7C3Q36102183-A56D35F3-10C0-45D2-9193-DA7ADB1A5983Q36186103-4E0EF000-1905-4301-8040-DC6EB3F0DDEDQ36197323-C98D1600-3AF5-4DDD-BBB9-E30D1D8563A0Q36989956-EB92BCE1-1800-4ABE-ACAA-629F097C0E3AQ37123206-3D13D475-A8A2-4324-8EF9-837F1EC4E8FFQ37314749-987F7745-2CE4-446B-B5DC-1A08EE9D51E7Q37397437-98D32519-C6C3-4C50-B654-78C855C3C311Q37715138-8454C8D5-39E4-4DE8-9A4D-4ADA9D4D98C8Q37724360-D8B0981A-D0FC-40B8-8EB5-92B5EA0C18D3Q37800300-6407097A-DB5E-43D1-A179-5763111116A1Q37872038-FE2A5986-552B-4B82-B368-5CB4895D193DQ38059445-82DD1B33-49BF-426F-ADD8-C2386334F598Q38102946-8D41AE8D-2D6A-4711-BFBC-E135368DFA3FQ38162780-F992765C-745A-462E-8DDE-BAF8009B5BF8Q38446147-E7B1DD47-7CD6-406A-A0D6-60BA06B63EA5Q38596084-BFB6730F-EB59-44CA-BD87-7605B20831EEQ40815460-6CF565B6-9039-4A25-A1ED-AF6A2B19BD6FQ44623048-71E9FF73-ECC8-4570-AA2A-3DC440057EAEQ45942560-DAF811DC-9290-4B4A-A15F-820C349DEC1CQ46260498-AE6775D8-76A9-46C3-86DB-09EFE45C8E92Q50975281-72904F5D-1207-4306-943A-78352DD3CDEFQ51472879-57B1CC8E-FEB1-41DD-B564-15DB02BAB37FQ52561176-5EC70AC8-D8A5-48DB-BC84-187B69A18DE4Q53089425-9998C6FC-B995-4F00-AD70-0FC7B031C902
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on May 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Current treatment of lupus nephritis.
@en
Current treatment of lupus nephritis.
@nl
type
label
Current treatment of lupus nephritis.
@en
Current treatment of lupus nephritis.
@nl
prefLabel
Current treatment of lupus nephritis.
@en
Current treatment of lupus nephritis.
@nl
P2860
P356
P1433
P1476
Current treatment of lupus nephritis.
@en
P2093
E M Ginzler
F A Houssiau
P2860
P304
P356
10.1177/0961203308090029
P577
2008-05-01T00:00:00Z